Optimisation of Hydromorphone - Naloxone Ratio for the Treatment of Pain (HMX3501)
This study has been completed.
Sponsor:
Mundipharma Research GmbH & Co KG
Information provided by:
Mundipharma Research GmbH & Co KG
ClinicalTrials.gov Identifier:
NCT00992576
First received: October 6, 2009
Last updated: February 14, 2012
Last verified: February 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | January 2012 |
| Primary Completion Date: | November 2011 (Final data collection date for primary outcome measure) |